Characterization of the anti-platelet actions of FK419, a novel non-peptide antagonist of platelet GPIIb/IIIa-Reference-Cited by-同舟云学术

Characterization of the anti-platelet actions of FK419, a novel non-peptide antagonist of platelet GPIIb/IIIa

Published:2004 Issue:4 Volume:61 Page:233-241
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Mihara Kayoko,Aoki Toshiaki,Moriguchi Akira,Yamamoto Hiroko,Maeda Masashi,Tojo Nobuteru,Yamanaka Toshio,Ohkubo Mitsuru,Matsuoka Nobuya,Seki Jiro,Mutoh Seitaro

Publisher

Wiley

Subject

Drug Discovery

Reference26 articles.

1. Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells.

2. Xemilofiban/Orbofiban: Insight into Drug Development

3. The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic antagonist

4. FK633: A Potent and Selective Platelet GPIIb/IIIa Antagonist

5. Aspirin reduces experimental cerebral blood flow in vivo

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enantioselective Synthesis of C2-Quaternary Indolin-3-ones by Pt-Catalyzed Alkynylation of 2-Aryl-3H-indol-3-one with Alkynylsilanes;The Journal of Organic Chemistry;2024-02-19

2. Catalytic Methylene Insertion between Amines and Terminal Alkynes via C–N Bond Cleavage of N,N-Dimethylacetamide: A Unique Route to Propargylic Amines;The Journal of Organic Chemistry;2023-01-16

3. Catalytic Enantioselective Cyclopropylalkynylation of Aldimines Generated In Situ from α-Amido Sulfones;Molecules;2022-06-11

4. Catalytic Enantioselective Cyclopropylalkynylation of Aldimines Generated In Situ from α-Amido Sulfones;MOLECULES;2022

5. An Addition of Terminal Alkynes to Phthalazin‐2‐Ium Bromide Catalyzed by Copper;Advanced Synthesis & Catalysis;2020-04-17